Atezolizumab/Bevacizumab beim hepatozellulären KarzinomAtezolizumab/Bevacizumab in hepatocellular carcinoma

被引：0
|
作者：
Fabian Kütting
Hakan Alakus
Christiane Bruns
机构：
[1] Universitätsklinikum Köln (AöR),Klinik für Gastroenterologie und Hepatologie
[2] Universitätsklinikum Köln (AöR),Klinik und Poliklinik für Allgemein‑, Viszeral
来源：
Der Onkologe | 2020年 / 26卷 / 10期
关键词：
D O I：
10.1007/s00761-020-00807-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：970 / 971
页数：1
相关论文
共 50 条
  • [41] Prediction for gastrointestinal bleeding in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
    Park, Kanghee
    Kim, Euichang
    Yang, Ji Won
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2023, 78 : S573 - S573
  • [42] Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
    Scheiner, Bernhard
    Sartoris, Riccardo
    D'Alessio, Antonio
    Fulgenzi, Claudia
    Pomej, Katharina
    Balcar, Lorenz
    Bouattour, Mohamed
    Sidali, Sabrina
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Schulze, Kornelius
    von Felden, Johann
    Hucke, Florian
    Shmanko, Kateryna
    Siebenhuner, Alexander
    Mertens, Joachim C.
    De Dosso, Sara
    Ebert, Matthias
    Teufel, Andreas
    Waldschmidt, Dirk-Thomas
    Radu, Iuliana Pompilia
    Krall, Anja
    Trauner, Michael
    Dufour, Jean-Francois
    Wege, Henning
    Weinmann, Arndt
    Trojan, Joerg
    Stauber, Rudolf E.
    Peck-Radosavljevic, Markus
    Hsu, Wei-Fan
    Vogel, Arndt
    Ronot, Maxime
    Pinato, David J.
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2023, 78 : S491 - S492
  • [43] Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
    Kudo, Masatoshi
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (03) : 435 - 439
  • [44] Toxicities and Outcomes of Radiation Therapy with Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
    Ludmir, Ethan
    Manzar, Gohar
    De, Brian
    Abana, Chike
    Lee, Sunyoung
    Javle, Milind
    Kaseb, Ahmed
    Vauthey, Jean-Nicolas
    Cao, Hop Tran
    Koong, Albert
    Smith, Grace
    Taniguchi, Cullen
    Holliday, Emma
    Das, Prajnan
    Koay, Eugene
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S1 - S2
  • [45] Atezolizumab and bevacizumab for hepatocellular carcinoma: mechanism, pharmacokinetics and future treatment strategies
    Liu, Xiufeng
    Lu, Yi
    Qin, Shukui
    FUTURE ONCOLOGY, 2021, 17 (17) : 2243 - 2256
  • [46] Atezolizumab/bevacizumab as downstaging in hepatocellular carcinoma: an intention-to-transplant analysis
    Maspero, Marianna
    Bhoori, Sherrie
    Fedele, Veronica
    Simonotti, Nicolo
    Bellia, Valentina
    Bongini, Marco
    Sposito, Carlo
    Mazzaferro, Vincenzo
    JOURNAL OF HEPATOLOGY, 2024, 80 : S438 - S438
  • [47] Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
    Ahmed, Faiza
    Onwumeh-Okwundu, Jennifer
    Yukselen, Zeynep
    Endaya Coronel, Maria-Kassandra
    Zaidi, Madiha
    Guntipalli, Prathima
    Garimella, Vamsi
    Gudapati, Sravya
    Mezidor, Marc Darlene
    Andrews, Kim
    Mouchli, Mohamad
    Shahini, Endrit
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (11) : 1813 - 1832
  • [48] Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
    Faiza Ahmed
    Jennifer Onwumeh-Okwundu
    Zeynep Yukselen
    Maria-Kassandra Endaya Coronel
    Madiha Zaidi
    Prathima Guntipalli
    Vamsi Garimella
    Sravya Gudapati
    Marc Darlene Mezidor
    Kim Andrews
    Mohamad Mouchli
    Endrit Shahini
    World Journal of Gastrointestinal Oncology, 2021, 13 (11) : 1813 - 1832
  • [49] Pathologie des Hepatozellulären KarzinomsPathology of hepatocellular carcinoma
    Thomas Longerich
    Peter Schirmacher
    Der Pathologe, 2022, 43 (1): : 67 - 78
  • [50] Leitlinie zum hepatozellulären KarzinomGuideline on hepatocellular carcinoma
    Thomas Helmberger
    Der Radiologe, 2022, 62 (3): : 197 - 199
12345